Skip to main content
Signal8

DWEK RAYMOND

SEC insider (Form 3/4/5 filer). CIK 0001231617. Director at UNITED THERAPEUTICS Corp (UTHR). 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 24, 2025. Located in SILVER SPRING, MD.

Companies DWEK RAYMOND has filed insider reports for

  • UNITED THERAPEUTICS Corp (UTHR): Director
DWEK RAYMOND profile photo

DWEK RAYMOND

CIK: 0001231617

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (42.9%)

Position reduction

Option Exercises (M)3 (42.9%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

UNITED THERAPEUTICS Corp logo
UTHR

UNITED THERAPEUTICS Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Jul 24, 2025
    Award

    Stock Options

    Direct
    3.7K shares-
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 21, 2025
    Exercise
    Direct
    3K shares at avg. $175.43$526K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 21, 2025
    Sale
    Direct
    3K shares at avg. $285.57$857K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 14, 2025
    Exercise
    Direct
    3K shares at avg. $175.43$526K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 14, 2025
    Sale
    Direct
    3K shares at avg. $285.16$855K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 7, 2025
    Exercise
    Direct
    4K shares at avg. $175.43$702K
  • UNITED THERAPEUTICS Corp logo
    UTHR

    UNITED THERAPEUTICS Corp

    Apr 7, 2025
    Sale
    Direct
    4K shares at avg. $284.55$1.1M

1-7 of 7